Selmeczy Z, Csóka B, Pacher P, Vizi E S, Haskó G
Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Inflamm Res. 2007 May;56(5):204-9. doi: 10.1007/s00011-006-6150-7.
In this study we investigated the effect of CGS 21680 (2-p-(2-Carboxyethyl)phenethylamino-5-N-ethylcarboxamidoadenosine hydrochloride), an adenosine A2A receptor agonist, in a model of dextran sulphate sodium (DSS)-induced colitis.
NMRI mice were fed 5 % (w/v) DSS, and were treated intraperitoneally with 0.5 mg/kg CGS 21680 or vehicle for 10 days. Changes of bodyweight, colon length, the incidence of rectal bleeding, levels of macrophage inflammatory protein (MIP)-1alpha, MIP-2, interferon gamma, interleukin (IL)-1beta, IL-12 and tumour necrosis factor-alpha from homogenates of colon biopsies, and the release of [3H]acetylcholine (ACh) from longitudinal muscle strip were determined.
DSS significantly decreased bodyweight, colon length, and it increased the incidence of rectal bleeding and levels of MIP-1alpha, MIP-2 and IL-1beta compared to DSS-untreated animals. CGS 21680 had no effect on these changes. No change could be observed in release of ACh in DSS-induced colitis with or without CGS 21680.
In summary, CGS 21680 is ineffective in ameliorating DSS-induced colitis in mice.
在本研究中,我们调查了腺苷A2A受体激动剂CGS 21680(2 - 对 -(2 - 羧乙基)苯乙氨基 - 5 - N - 乙基甲酰胺基腺苷盐酸盐)在葡聚糖硫酸钠(DSS)诱导的结肠炎模型中的作用。
给NMRI小鼠喂食5%(w/v)的DSS,并腹腔注射0.5 mg/kg的CGS 21680或赋形剂,持续10天。测定体重变化、结肠长度、直肠出血发生率、结肠活检匀浆中巨噬细胞炎性蛋白(MIP)-1α、MIP - 2、干扰素γ、白细胞介素(IL)-1β、IL - 12和肿瘤坏死因子 - α的水平,以及纵向肌条中[3H]乙酰胆碱(ACh)的释放。
与未用DSS处理的动物相比,DSS显著降低了体重和结肠长度,并增加了直肠出血发生率以及MIP - 1α、MIP - 2和IL - 1β的水平。CGS 21680对这些变化没有影响。在有或没有CGS 21680的DSS诱导的结肠炎中,未观察到ACh释放的变化。
总之,CGS 21680在改善小鼠DSS诱导的结肠炎方面无效。